Long-Lived Patients With Primary Myelofibrosis: What Predicts a 20+ Year Survival?
A retrospective study identified prognostic factors for long survival — 20+ years — in patients with primary myelofibrosis.
Hematologic Cancers
HEMATALOGIC CANCERS
Hematologic Cancers News & Features
Uncertainty Common in Primary Family Caregivers of Patients With Multiple Myeloma
Researchers find trends among physical and emotional challenges associated with being the primary family caregiver of a patient with multiple myeloma.
Cancer Clinic Specializes in Assessments, Treatment of the Nonfrail Elderly
Oncologist Ashley Rosko, MD, has a unique perspective on patient age: Biological age is more important than chronological age. Dr Rosko is founder and director of the Cancer and Aging Resiliency (CARE) Clinic, a multidisciplinary clinic designed to address the needs of older adults with cancer. The clinic is located in The James Cancer Hospital…
Risk of Hospitalization Remains High for Survivors of Childhood Leukemia
A retrospective study using a cohort of the ALiCCS Study sought to determine hospitalization risks among survivors of leukemia during childhood 20 years after diagnosis.
FDA Approves Tagraxofusp, First Approved Treatment for a Rare, Aggressive Hematologic Cancer
FDA grants approval to tagraxofusp-erzs (Elzonris), a first treatment for blastic plasmacytoid dentritic cell neoplasm and the first therapy to target CD123.
Want to read more?
Please login or register first to view this content.
Next post in Hematologic Cancers
